EAU 2017 - Bladder Cancer

Viewing 1-20 of 23 articles

EAU 2017: Perioperative chemotherapy does not improve disease free survival in upper tract urothelial carcinoma: a population based analysis

EAU 2017: State-of-the-art Lecture: How will Immunotherapy Change the Treatment Paradigm?

EAU 2017: State-of-the-art Lecture: Is There Still a Role for Chemotherapy?

EAU 2017: Updated meta-analysis (MA) of salvage therapy for metastatic urothelial cancer (mUC): Comparing outcomes of immunotherapy (IT) vs. single agent and doublet chemotherapy (CT)

EAU 2017: State of the Art Lecture: Enhanced Recovery After Surgery (ERAS) for Bladder Cancer: Non-Surgical Options to Improve Outcomes of Cystectomy

EAU 2017: State of the Art Debate - Evidence for extent of lymphadenectomy in urothelial bladder cancer

EAU 2017: Debate - Do we need to follow-up in low grade bladder tumor after 12 months?-Yes (EAU Guidelines)

EAU 2017: Perfect adjuvant treatment

EAU 2017: Perfect transurethral resection

EAU 2017: Pure histological variants are associated with poor survival at radical cystectomy in patients with bladder cancer

EAU 2017: Efficacy of long acting sandostatin on reducing mucus production in patients with ileal neobladder

EAU 2017: Increasing use of incontinent urinary diversion: A total population analysis of radical cystectomies in Germany from 2006 to 2013

EAU 2017: The use of antibiotic prophylaxis in patients undergoing radical cystectomy for bladder cancer

EAU 2017: 20-gene expression signature to predict lymph node positive disease at radical cystectomy for muscle-invasive bladder cancer: Not validated

EAU 2017: IMvigor010, a phase III study of adjuvant atezolizumab vs observation in patients (pts) with muscle-invasive urothelial carcinoma (UC)

EAU 2017: PURE01: An open label, single-arm, phase 2 study of the anti-programmed death (PD)-1 monoclonal antibody (moAb) pembrolizumab for neoadjuvant therapy of muscle-invasive urothelial bladder carcinoma (miUBC)

EAU 2017: Comparison effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder

EAU 2017: Can radical cystectomy be performed safely in the metastatic setting? Location of metastatic bladder cancer as a determinant of in-hospital mortality

EAU 2017: Debate on bladder cancer surgery: open cystectomy is still the way - Con

EAU 2017: Multimodal bladder preservation technique for muscle invasive bladder cancer: Results from a prospective trial

1
2